The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes
Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have bee...
Ausführliche Beschreibung
Autor*in: |
Xiao-Mei Song [verfasserIn] Qing-Ling Li [verfasserIn] Feng Guo [verfasserIn] Hong Peng [verfasserIn] Jin-Jun Guo [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2018 |
---|
Schlagwörter: |
Single nucleotide polymorphisms (SNPs) Inducible T-cell costimulator (ICOS) Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) |
---|
Übergeordnetes Werk: |
In: Annals of Hepatology - Elsevier, 2021, 17(2018), 6, Seite 940-947 |
---|---|
Übergeordnetes Werk: |
volume:17 ; year:2018 ; number:6 ; pages:940-947 |
Links: |
---|
DOI / URN: |
10.5604/01.3001.0012.7194 |
---|
Katalog-ID: |
DOAJ070807221 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ070807221 | ||
003 | DE-627 | ||
005 | 20230309094553.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.5604/01.3001.0012.7194 |2 doi | |
035 | |a (DE-627)DOAJ070807221 | ||
035 | |a (DE-599)DOAJd0c47efb225a452ca583ff07a84aff53 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC581-951 | |
100 | 0 | |a Xiao-Mei Song |e verfasserin |4 aut | |
245 | 1 | 4 | |a The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have been confirmed in previous studies. This study was to explore the effects of ICOS single nucleotide polymorphisms in HBV subtypes and their interactions with viral mutations on HBV infection outcomes.Material and methods. A total of 1,636 Han Chinese individuals were recruited, including 47 asymptomatic HBV carriers (ASC), 353 chronic hepatitis B (CHB) patients, 327 HBV-related liver cirrhosis (LC) patients, 193 HBV-related hepatocellular carcinoma (HCC) patients, 464 patients with spontaneous recovery from HBV infection (SR), and 252 healthy controls (HC). DNA samples from these subjects were genotyped for four ICOS SNPs (rs11883722, rs10932029, rs1559931, and rs4675379). Direct sequencing was used to determine the HBV mutations in the enhancer II, basal core promoter, and pre-core regions.Results. We found that the genotype “TC” of ICOS rs10932029 SNP was associated with decreased HBV-related LC risk in the genotype C group. Additionally, the A1762T, G1764A and A1762T/G1764A mutations were associated with an increased risk of LC in the genotype C group. Further study indicated that interactions between ICOS rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations significantly decreased the LC risk in the genotype C group.Conclusion. The rs10932029 genotype “TC” might be an LC-protective factor for HBV genotype C infection. The interactions between the rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations could decrease the risk of LC. | ||
650 | 4 | |a Hepatitis B virus(HBV) | |
650 | 4 | |a Single nucleotide polymorphisms (SNPs) | |
650 | 4 | |a Inducible T-cell costimulator (ICOS) | |
650 | 4 | |a Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) | |
653 | 0 | |a Specialties of internal medicine | |
700 | 0 | |a Qing-Ling Li |e verfasserin |4 aut | |
700 | 0 | |a Feng Guo |e verfasserin |4 aut | |
700 | 0 | |a Hong Peng |e verfasserin |4 aut | |
700 | 0 | |a Jin-Jun Guo |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Annals of Hepatology |d Elsevier, 2021 |g 17(2018), 6, Seite 940-947 |w (DE-627)DOAJ078617936 |x 26595982 |7 nnns |
773 | 1 | 8 | |g volume:17 |g year:2018 |g number:6 |g pages:940-947 |
856 | 4 | 0 | |u https://doi.org/10.5604/01.3001.0012.7194 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/d0c47efb225a452ca583ff07a84aff53 |z kostenfrei |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1665268119310567 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1665-2681 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_2002 | ||
951 | |a AR | ||
952 | |d 17 |j 2018 |e 6 |h 940-947 |
author_variant |
x m s xms q l l qll f g fg h p hp j j g jjg |
---|---|
matchkey_str |
article:26595982:2018----::hefcoioplmrhsitrcinwthvuainohvu |
hierarchy_sort_str |
2018 |
callnumber-subject-code |
RC |
publishDate |
2018 |
allfields |
10.5604/01.3001.0012.7194 doi (DE-627)DOAJ070807221 (DE-599)DOAJd0c47efb225a452ca583ff07a84aff53 DE-627 ger DE-627 rakwb eng RC581-951 Xiao-Mei Song verfasserin aut The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have been confirmed in previous studies. This study was to explore the effects of ICOS single nucleotide polymorphisms in HBV subtypes and their interactions with viral mutations on HBV infection outcomes.Material and methods. A total of 1,636 Han Chinese individuals were recruited, including 47 asymptomatic HBV carriers (ASC), 353 chronic hepatitis B (CHB) patients, 327 HBV-related liver cirrhosis (LC) patients, 193 HBV-related hepatocellular carcinoma (HCC) patients, 464 patients with spontaneous recovery from HBV infection (SR), and 252 healthy controls (HC). DNA samples from these subjects were genotyped for four ICOS SNPs (rs11883722, rs10932029, rs1559931, and rs4675379). Direct sequencing was used to determine the HBV mutations in the enhancer II, basal core promoter, and pre-core regions.Results. We found that the genotype “TC” of ICOS rs10932029 SNP was associated with decreased HBV-related LC risk in the genotype C group. Additionally, the A1762T, G1764A and A1762T/G1764A mutations were associated with an increased risk of LC in the genotype C group. Further study indicated that interactions between ICOS rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations significantly decreased the LC risk in the genotype C group.Conclusion. The rs10932029 genotype “TC” might be an LC-protective factor for HBV genotype C infection. The interactions between the rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations could decrease the risk of LC. Hepatitis B virus(HBV) Single nucleotide polymorphisms (SNPs) Inducible T-cell costimulator (ICOS) Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) Specialties of internal medicine Qing-Ling Li verfasserin aut Feng Guo verfasserin aut Hong Peng verfasserin aut Jin-Jun Guo verfasserin aut In Annals of Hepatology Elsevier, 2021 17(2018), 6, Seite 940-947 (DE-627)DOAJ078617936 26595982 nnns volume:17 year:2018 number:6 pages:940-947 https://doi.org/10.5604/01.3001.0012.7194 kostenfrei https://doaj.org/article/d0c47efb225a452ca583ff07a84aff53 kostenfrei http://www.sciencedirect.com/science/article/pii/S1665268119310567 kostenfrei https://doaj.org/toc/1665-2681 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 AR 17 2018 6 940-947 |
spelling |
10.5604/01.3001.0012.7194 doi (DE-627)DOAJ070807221 (DE-599)DOAJd0c47efb225a452ca583ff07a84aff53 DE-627 ger DE-627 rakwb eng RC581-951 Xiao-Mei Song verfasserin aut The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have been confirmed in previous studies. This study was to explore the effects of ICOS single nucleotide polymorphisms in HBV subtypes and their interactions with viral mutations on HBV infection outcomes.Material and methods. A total of 1,636 Han Chinese individuals were recruited, including 47 asymptomatic HBV carriers (ASC), 353 chronic hepatitis B (CHB) patients, 327 HBV-related liver cirrhosis (LC) patients, 193 HBV-related hepatocellular carcinoma (HCC) patients, 464 patients with spontaneous recovery from HBV infection (SR), and 252 healthy controls (HC). DNA samples from these subjects were genotyped for four ICOS SNPs (rs11883722, rs10932029, rs1559931, and rs4675379). Direct sequencing was used to determine the HBV mutations in the enhancer II, basal core promoter, and pre-core regions.Results. We found that the genotype “TC” of ICOS rs10932029 SNP was associated with decreased HBV-related LC risk in the genotype C group. Additionally, the A1762T, G1764A and A1762T/G1764A mutations were associated with an increased risk of LC in the genotype C group. Further study indicated that interactions between ICOS rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations significantly decreased the LC risk in the genotype C group.Conclusion. The rs10932029 genotype “TC” might be an LC-protective factor for HBV genotype C infection. The interactions between the rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations could decrease the risk of LC. Hepatitis B virus(HBV) Single nucleotide polymorphisms (SNPs) Inducible T-cell costimulator (ICOS) Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) Specialties of internal medicine Qing-Ling Li verfasserin aut Feng Guo verfasserin aut Hong Peng verfasserin aut Jin-Jun Guo verfasserin aut In Annals of Hepatology Elsevier, 2021 17(2018), 6, Seite 940-947 (DE-627)DOAJ078617936 26595982 nnns volume:17 year:2018 number:6 pages:940-947 https://doi.org/10.5604/01.3001.0012.7194 kostenfrei https://doaj.org/article/d0c47efb225a452ca583ff07a84aff53 kostenfrei http://www.sciencedirect.com/science/article/pii/S1665268119310567 kostenfrei https://doaj.org/toc/1665-2681 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 AR 17 2018 6 940-947 |
allfields_unstemmed |
10.5604/01.3001.0012.7194 doi (DE-627)DOAJ070807221 (DE-599)DOAJd0c47efb225a452ca583ff07a84aff53 DE-627 ger DE-627 rakwb eng RC581-951 Xiao-Mei Song verfasserin aut The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have been confirmed in previous studies. This study was to explore the effects of ICOS single nucleotide polymorphisms in HBV subtypes and their interactions with viral mutations on HBV infection outcomes.Material and methods. A total of 1,636 Han Chinese individuals were recruited, including 47 asymptomatic HBV carriers (ASC), 353 chronic hepatitis B (CHB) patients, 327 HBV-related liver cirrhosis (LC) patients, 193 HBV-related hepatocellular carcinoma (HCC) patients, 464 patients with spontaneous recovery from HBV infection (SR), and 252 healthy controls (HC). DNA samples from these subjects were genotyped for four ICOS SNPs (rs11883722, rs10932029, rs1559931, and rs4675379). Direct sequencing was used to determine the HBV mutations in the enhancer II, basal core promoter, and pre-core regions.Results. We found that the genotype “TC” of ICOS rs10932029 SNP was associated with decreased HBV-related LC risk in the genotype C group. Additionally, the A1762T, G1764A and A1762T/G1764A mutations were associated with an increased risk of LC in the genotype C group. Further study indicated that interactions between ICOS rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations significantly decreased the LC risk in the genotype C group.Conclusion. The rs10932029 genotype “TC” might be an LC-protective factor for HBV genotype C infection. The interactions between the rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations could decrease the risk of LC. Hepatitis B virus(HBV) Single nucleotide polymorphisms (SNPs) Inducible T-cell costimulator (ICOS) Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) Specialties of internal medicine Qing-Ling Li verfasserin aut Feng Guo verfasserin aut Hong Peng verfasserin aut Jin-Jun Guo verfasserin aut In Annals of Hepatology Elsevier, 2021 17(2018), 6, Seite 940-947 (DE-627)DOAJ078617936 26595982 nnns volume:17 year:2018 number:6 pages:940-947 https://doi.org/10.5604/01.3001.0012.7194 kostenfrei https://doaj.org/article/d0c47efb225a452ca583ff07a84aff53 kostenfrei http://www.sciencedirect.com/science/article/pii/S1665268119310567 kostenfrei https://doaj.org/toc/1665-2681 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 AR 17 2018 6 940-947 |
allfieldsGer |
10.5604/01.3001.0012.7194 doi (DE-627)DOAJ070807221 (DE-599)DOAJd0c47efb225a452ca583ff07a84aff53 DE-627 ger DE-627 rakwb eng RC581-951 Xiao-Mei Song verfasserin aut The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have been confirmed in previous studies. This study was to explore the effects of ICOS single nucleotide polymorphisms in HBV subtypes and their interactions with viral mutations on HBV infection outcomes.Material and methods. A total of 1,636 Han Chinese individuals were recruited, including 47 asymptomatic HBV carriers (ASC), 353 chronic hepatitis B (CHB) patients, 327 HBV-related liver cirrhosis (LC) patients, 193 HBV-related hepatocellular carcinoma (HCC) patients, 464 patients with spontaneous recovery from HBV infection (SR), and 252 healthy controls (HC). DNA samples from these subjects were genotyped for four ICOS SNPs (rs11883722, rs10932029, rs1559931, and rs4675379). Direct sequencing was used to determine the HBV mutations in the enhancer II, basal core promoter, and pre-core regions.Results. We found that the genotype “TC” of ICOS rs10932029 SNP was associated with decreased HBV-related LC risk in the genotype C group. Additionally, the A1762T, G1764A and A1762T/G1764A mutations were associated with an increased risk of LC in the genotype C group. Further study indicated that interactions between ICOS rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations significantly decreased the LC risk in the genotype C group.Conclusion. The rs10932029 genotype “TC” might be an LC-protective factor for HBV genotype C infection. The interactions between the rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations could decrease the risk of LC. Hepatitis B virus(HBV) Single nucleotide polymorphisms (SNPs) Inducible T-cell costimulator (ICOS) Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) Specialties of internal medicine Qing-Ling Li verfasserin aut Feng Guo verfasserin aut Hong Peng verfasserin aut Jin-Jun Guo verfasserin aut In Annals of Hepatology Elsevier, 2021 17(2018), 6, Seite 940-947 (DE-627)DOAJ078617936 26595982 nnns volume:17 year:2018 number:6 pages:940-947 https://doi.org/10.5604/01.3001.0012.7194 kostenfrei https://doaj.org/article/d0c47efb225a452ca583ff07a84aff53 kostenfrei http://www.sciencedirect.com/science/article/pii/S1665268119310567 kostenfrei https://doaj.org/toc/1665-2681 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 AR 17 2018 6 940-947 |
allfieldsSound |
10.5604/01.3001.0012.7194 doi (DE-627)DOAJ070807221 (DE-599)DOAJd0c47efb225a452ca583ff07a84aff53 DE-627 ger DE-627 rakwb eng RC581-951 Xiao-Mei Song verfasserin aut The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have been confirmed in previous studies. This study was to explore the effects of ICOS single nucleotide polymorphisms in HBV subtypes and their interactions with viral mutations on HBV infection outcomes.Material and methods. A total of 1,636 Han Chinese individuals were recruited, including 47 asymptomatic HBV carriers (ASC), 353 chronic hepatitis B (CHB) patients, 327 HBV-related liver cirrhosis (LC) patients, 193 HBV-related hepatocellular carcinoma (HCC) patients, 464 patients with spontaneous recovery from HBV infection (SR), and 252 healthy controls (HC). DNA samples from these subjects were genotyped for four ICOS SNPs (rs11883722, rs10932029, rs1559931, and rs4675379). Direct sequencing was used to determine the HBV mutations in the enhancer II, basal core promoter, and pre-core regions.Results. We found that the genotype “TC” of ICOS rs10932029 SNP was associated with decreased HBV-related LC risk in the genotype C group. Additionally, the A1762T, G1764A and A1762T/G1764A mutations were associated with an increased risk of LC in the genotype C group. Further study indicated that interactions between ICOS rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations significantly decreased the LC risk in the genotype C group.Conclusion. The rs10932029 genotype “TC” might be an LC-protective factor for HBV genotype C infection. The interactions between the rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations could decrease the risk of LC. Hepatitis B virus(HBV) Single nucleotide polymorphisms (SNPs) Inducible T-cell costimulator (ICOS) Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) Specialties of internal medicine Qing-Ling Li verfasserin aut Feng Guo verfasserin aut Hong Peng verfasserin aut Jin-Jun Guo verfasserin aut In Annals of Hepatology Elsevier, 2021 17(2018), 6, Seite 940-947 (DE-627)DOAJ078617936 26595982 nnns volume:17 year:2018 number:6 pages:940-947 https://doi.org/10.5604/01.3001.0012.7194 kostenfrei https://doaj.org/article/d0c47efb225a452ca583ff07a84aff53 kostenfrei http://www.sciencedirect.com/science/article/pii/S1665268119310567 kostenfrei https://doaj.org/toc/1665-2681 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 AR 17 2018 6 940-947 |
language |
English |
source |
In Annals of Hepatology 17(2018), 6, Seite 940-947 volume:17 year:2018 number:6 pages:940-947 |
sourceStr |
In Annals of Hepatology 17(2018), 6, Seite 940-947 volume:17 year:2018 number:6 pages:940-947 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Hepatitis B virus(HBV) Single nucleotide polymorphisms (SNPs) Inducible T-cell costimulator (ICOS) Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) Specialties of internal medicine |
isfreeaccess_bool |
true |
container_title |
Annals of Hepatology |
authorswithroles_txt_mv |
Xiao-Mei Song @@aut@@ Qing-Ling Li @@aut@@ Feng Guo @@aut@@ Hong Peng @@aut@@ Jin-Jun Guo @@aut@@ |
publishDateDaySort_date |
2018-01-01T00:00:00Z |
hierarchy_top_id |
DOAJ078617936 |
id |
DOAJ070807221 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ070807221</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309094553.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.5604/01.3001.0012.7194</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ070807221</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJd0c47efb225a452ca583ff07a84aff53</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC581-951</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Xiao-Mei Song</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have been confirmed in previous studies. This study was to explore the effects of ICOS single nucleotide polymorphisms in HBV subtypes and their interactions with viral mutations on HBV infection outcomes.Material and methods. A total of 1,636 Han Chinese individuals were recruited, including 47 asymptomatic HBV carriers (ASC), 353 chronic hepatitis B (CHB) patients, 327 HBV-related liver cirrhosis (LC) patients, 193 HBV-related hepatocellular carcinoma (HCC) patients, 464 patients with spontaneous recovery from HBV infection (SR), and 252 healthy controls (HC). DNA samples from these subjects were genotyped for four ICOS SNPs (rs11883722, rs10932029, rs1559931, and rs4675379). Direct sequencing was used to determine the HBV mutations in the enhancer II, basal core promoter, and pre-core regions.Results. We found that the genotype “TC” of ICOS rs10932029 SNP was associated with decreased HBV-related LC risk in the genotype C group. Additionally, the A1762T, G1764A and A1762T/G1764A mutations were associated with an increased risk of LC in the genotype C group. Further study indicated that interactions between ICOS rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations significantly decreased the LC risk in the genotype C group.Conclusion. The rs10932029 genotype “TC” might be an LC-protective factor for HBV genotype C infection. The interactions between the rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations could decrease the risk of LC.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis B virus(HBV)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Single nucleotide polymorphisms (SNPs)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Inducible T-cell costimulator (ICOS)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region)</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Specialties of internal medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Qing-Ling Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Feng Guo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hong Peng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jin-Jun Guo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Annals of Hepatology</subfield><subfield code="d">Elsevier, 2021</subfield><subfield code="g">17(2018), 6, Seite 940-947</subfield><subfield code="w">(DE-627)DOAJ078617936</subfield><subfield code="x">26595982</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:17</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:940-947</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.5604/01.3001.0012.7194</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/d0c47efb225a452ca583ff07a84aff53</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S1665268119310567</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1665-2681</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2002</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">17</subfield><subfield code="j">2018</subfield><subfield code="e">6</subfield><subfield code="h">940-947</subfield></datafield></record></collection>
|
callnumber-first |
R - Medicine |
author |
Xiao-Mei Song |
spellingShingle |
Xiao-Mei Song misc RC581-951 misc Hepatitis B virus(HBV) misc Single nucleotide polymorphisms (SNPs) misc Inducible T-cell costimulator (ICOS) misc Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) misc Specialties of internal medicine The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes |
authorStr |
Xiao-Mei Song |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)DOAJ078617936 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
RC581-951 |
illustrated |
Not Illustrated |
issn |
26595982 |
topic_title |
RC581-951 The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes Hepatitis B virus(HBV) Single nucleotide polymorphisms (SNPs) Inducible T-cell costimulator (ICOS) Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) |
topic |
misc RC581-951 misc Hepatitis B virus(HBV) misc Single nucleotide polymorphisms (SNPs) misc Inducible T-cell costimulator (ICOS) misc Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) misc Specialties of internal medicine |
topic_unstemmed |
misc RC581-951 misc Hepatitis B virus(HBV) misc Single nucleotide polymorphisms (SNPs) misc Inducible T-cell costimulator (ICOS) misc Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) misc Specialties of internal medicine |
topic_browse |
misc RC581-951 misc Hepatitis B virus(HBV) misc Single nucleotide polymorphisms (SNPs) misc Inducible T-cell costimulator (ICOS) misc Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region) misc Specialties of internal medicine |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Annals of Hepatology |
hierarchy_parent_id |
DOAJ078617936 |
hierarchy_top_title |
Annals of Hepatology |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)DOAJ078617936 |
title |
The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes |
ctrlnum |
(DE-627)DOAJ070807221 (DE-599)DOAJd0c47efb225a452ca583ff07a84aff53 |
title_full |
The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes |
author_sort |
Xiao-Mei Song |
journal |
Annals of Hepatology |
journalStr |
Annals of Hepatology |
callnumber-first-code |
R |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2018 |
contenttype_str_mv |
txt |
container_start_page |
940 |
author_browse |
Xiao-Mei Song Qing-Ling Li Feng Guo Hong Peng Jin-Jun Guo |
container_volume |
17 |
class |
RC581-951 |
format_se |
Elektronische Aufsätze |
author-letter |
Xiao-Mei Song |
doi_str_mv |
10.5604/01.3001.0012.7194 |
author2-role |
verfasserin |
title_sort |
effect of icos polymorphism interactions with hbv mutations on hbv subtype infection outcomes |
callnumber |
RC581-951 |
title_auth |
The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes |
abstract |
Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have been confirmed in previous studies. This study was to explore the effects of ICOS single nucleotide polymorphisms in HBV subtypes and their interactions with viral mutations on HBV infection outcomes.Material and methods. A total of 1,636 Han Chinese individuals were recruited, including 47 asymptomatic HBV carriers (ASC), 353 chronic hepatitis B (CHB) patients, 327 HBV-related liver cirrhosis (LC) patients, 193 HBV-related hepatocellular carcinoma (HCC) patients, 464 patients with spontaneous recovery from HBV infection (SR), and 252 healthy controls (HC). DNA samples from these subjects were genotyped for four ICOS SNPs (rs11883722, rs10932029, rs1559931, and rs4675379). Direct sequencing was used to determine the HBV mutations in the enhancer II, basal core promoter, and pre-core regions.Results. We found that the genotype “TC” of ICOS rs10932029 SNP was associated with decreased HBV-related LC risk in the genotype C group. Additionally, the A1762T, G1764A and A1762T/G1764A mutations were associated with an increased risk of LC in the genotype C group. Further study indicated that interactions between ICOS rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations significantly decreased the LC risk in the genotype C group.Conclusion. The rs10932029 genotype “TC” might be an LC-protective factor for HBV genotype C infection. The interactions between the rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations could decrease the risk of LC. |
abstractGer |
Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have been confirmed in previous studies. This study was to explore the effects of ICOS single nucleotide polymorphisms in HBV subtypes and their interactions with viral mutations on HBV infection outcomes.Material and methods. A total of 1,636 Han Chinese individuals were recruited, including 47 asymptomatic HBV carriers (ASC), 353 chronic hepatitis B (CHB) patients, 327 HBV-related liver cirrhosis (LC) patients, 193 HBV-related hepatocellular carcinoma (HCC) patients, 464 patients with spontaneous recovery from HBV infection (SR), and 252 healthy controls (HC). DNA samples from these subjects were genotyped for four ICOS SNPs (rs11883722, rs10932029, rs1559931, and rs4675379). Direct sequencing was used to determine the HBV mutations in the enhancer II, basal core promoter, and pre-core regions.Results. We found that the genotype “TC” of ICOS rs10932029 SNP was associated with decreased HBV-related LC risk in the genotype C group. Additionally, the A1762T, G1764A and A1762T/G1764A mutations were associated with an increased risk of LC in the genotype C group. Further study indicated that interactions between ICOS rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations significantly decreased the LC risk in the genotype C group.Conclusion. The rs10932029 genotype “TC” might be an LC-protective factor for HBV genotype C infection. The interactions between the rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations could decrease the risk of LC. |
abstract_unstemmed |
Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have been confirmed in previous studies. This study was to explore the effects of ICOS single nucleotide polymorphisms in HBV subtypes and their interactions with viral mutations on HBV infection outcomes.Material and methods. A total of 1,636 Han Chinese individuals were recruited, including 47 asymptomatic HBV carriers (ASC), 353 chronic hepatitis B (CHB) patients, 327 HBV-related liver cirrhosis (LC) patients, 193 HBV-related hepatocellular carcinoma (HCC) patients, 464 patients with spontaneous recovery from HBV infection (SR), and 252 healthy controls (HC). DNA samples from these subjects were genotyped for four ICOS SNPs (rs11883722, rs10932029, rs1559931, and rs4675379). Direct sequencing was used to determine the HBV mutations in the enhancer II, basal core promoter, and pre-core regions.Results. We found that the genotype “TC” of ICOS rs10932029 SNP was associated with decreased HBV-related LC risk in the genotype C group. Additionally, the A1762T, G1764A and A1762T/G1764A mutations were associated with an increased risk of LC in the genotype C group. Further study indicated that interactions between ICOS rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations significantly decreased the LC risk in the genotype C group.Conclusion. The rs10932029 genotype “TC” might be an LC-protective factor for HBV genotype C infection. The interactions between the rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations could decrease the risk of LC. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2002 |
container_issue |
6 |
title_short |
The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes |
url |
https://doi.org/10.5604/01.3001.0012.7194 https://doaj.org/article/d0c47efb225a452ca583ff07a84aff53 http://www.sciencedirect.com/science/article/pii/S1665268119310567 https://doaj.org/toc/1665-2681 |
remote_bool |
true |
author2 |
Qing-Ling Li Feng Guo Hong Peng Jin-Jun Guo |
author2Str |
Qing-Ling Li Feng Guo Hong Peng Jin-Jun Guo |
ppnlink |
DOAJ078617936 |
callnumber-subject |
RC - Internal Medicine |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.5604/01.3001.0012.7194 |
callnumber-a |
RC581-951 |
up_date |
2024-07-03T16:49:13.639Z |
_version_ |
1803577305217368064 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ070807221</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230309094553.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230228s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.5604/01.3001.0012.7194</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ070807221</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJd0c47efb225a452ca583ff07a84aff53</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC581-951</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Xiao-Mei Song</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Introduction and aim. Hepatitis B virus (HBV) infection remains a public health problem worldwide. In addition, HBV infection results are influenced by various virological, immunological, and genetic factors. Inducible T-cell costimulator (ICOS) polymorphisms involving chronic HBV infection have been confirmed in previous studies. This study was to explore the effects of ICOS single nucleotide polymorphisms in HBV subtypes and their interactions with viral mutations on HBV infection outcomes.Material and methods. A total of 1,636 Han Chinese individuals were recruited, including 47 asymptomatic HBV carriers (ASC), 353 chronic hepatitis B (CHB) patients, 327 HBV-related liver cirrhosis (LC) patients, 193 HBV-related hepatocellular carcinoma (HCC) patients, 464 patients with spontaneous recovery from HBV infection (SR), and 252 healthy controls (HC). DNA samples from these subjects were genotyped for four ICOS SNPs (rs11883722, rs10932029, rs1559931, and rs4675379). Direct sequencing was used to determine the HBV mutations in the enhancer II, basal core promoter, and pre-core regions.Results. We found that the genotype “TC” of ICOS rs10932029 SNP was associated with decreased HBV-related LC risk in the genotype C group. Additionally, the A1762T, G1764A and A1762T/G1764A mutations were associated with an increased risk of LC in the genotype C group. Further study indicated that interactions between ICOS rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations significantly decreased the LC risk in the genotype C group.Conclusion. The rs10932029 genotype “TC” might be an LC-protective factor for HBV genotype C infection. The interactions between the rs10932029 genotype “TC” and A1762T or A1762T/G1764A mutations could decrease the risk of LC.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hepatitis B virus(HBV)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Single nucleotide polymorphisms (SNPs)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Inducible T-cell costimulator (ICOS)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Enhancer II/ basal core promoter/pre-core region (EnhII/BCP/PC region)</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Specialties of internal medicine</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Qing-Ling Li</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Feng Guo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hong Peng</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Jin-Jun Guo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Annals of Hepatology</subfield><subfield code="d">Elsevier, 2021</subfield><subfield code="g">17(2018), 6, Seite 940-947</subfield><subfield code="w">(DE-627)DOAJ078617936</subfield><subfield code="x">26595982</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:17</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:940-947</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.5604/01.3001.0012.7194</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/d0c47efb225a452ca583ff07a84aff53</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/article/pii/S1665268119310567</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1665-2681</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2002</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">17</subfield><subfield code="j">2018</subfield><subfield code="e">6</subfield><subfield code="h">940-947</subfield></datafield></record></collection>
|
score |
7.4004354 |